Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer - PubMed (original) (raw)
Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer
M J Clare-Salzler et al. J Clin Invest. 1992 Sep.
Abstract
The purpose of this study was to determine the effect of dendritic cell (DC) transfers on the incidence of diabetes in female nonobese diabetic (NOD) mice. Groups of 4-wk-old NOD female mice were given a single foot pad of DCs (70-90% purity) isolated from the draining lymph nodes (LN) of the pancreas (PLN), the cervical LNs, or the axillary/inguinal LNs. In addition, other groups of NOD mice received purified spleen DCs, purified PLN T cells (the major contaminating population in DC preparations), or the injection vehicle PBS. All groups were monitored for diabetes for one year. Significant protection from diabetes was observed in NOD mice receiving greater than 1 x 10(4) PLN DCs in comparison to mice receiving other DCs populations, PLN T cells, or PBS (P less than 0.05). The pancreata of NOD mice that received PLN DCs demonstrated significantly lower levels of lymphocytic infiltration in the islets that age-sex matched nondiabetic female NOD control mice (P less than 0.05). LN cells from nondiabetic NOD mice that received PLN DC protected irradiated female recipients from the adoptive transfer of diabetes to a greater degree than LN cells from age and sex matched nondiabetic female NOD mice that did not receive PLN DC transfers at 36 d (P = 0.014) and at 1 yr (P = 0.0015) after transfer. These data suggest that the PLN DC transfers are able to modulate autoimmunity and limit diabetes expression in the NOD mouse. PLN DCs transfers may regulate autoimmunity by the induction of regulatory cells.
Similar articles
- Marked dendritic cell-T cell cluster formation in the pancreatic lymph node of the non-obese diabetic mouse.
Clare-Salzler M, Mullen Y. Clare-Salzler M, et al. Immunology. 1992 Jul;76(3):478-84. Immunology. 1992. PMID: 1356097 Free PMC article. - Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice.
Creusot RJ, Yaghoubi SS, Kodama K, Dang DN, Dang VH, Breckpot K, Thielemans K, Gambhir SS, Fathman CG. Creusot RJ, et al. Clin Immunol. 2008 May;127(2):176-87. doi: 10.1016/j.clim.2007.12.009. Epub 2008 Mar 12. Clin Immunol. 2008. PMID: 18337172 Free PMC article. - Dendritic cell immunotherapy for autoimmune diabetes.
Feili-Hariri M, Flores RR, Vasquez AC, Morel PA. Feili-Hariri M, et al. Immunol Res. 2006;36(1-3):167-73. doi: 10.1385/IR:36:1:167. Immunol Res. 2006. PMID: 17337777 Review. - The immunotherapeutic potential of dendritic cells in type 1 diabetes.
Mukherjee G, Dilorenzo TP. Mukherjee G, et al. Clin Exp Immunol. 2010 Aug;161(2):197-207. doi: 10.1111/j.1365-2249.2010.04157.x. Epub 2010 May 10. Clin Exp Immunol. 2010. PMID: 20491789 Free PMC article. Review.
Cited by
- GRAS-microparticle microarrays identify dendritic cell tolerogenic marker-inducing formulations.
Carstens MR, Wasserfall CH, Acharya AP, Lewis J, Agrawal N, Koenders K, Bracho-Sanchez E, Keselowsky BG. Carstens MR, et al. Lab Chip. 2021 Sep 14;21(18):3598-3613. doi: 10.1039/d1lc00096a. Lab Chip. 2021. PMID: 34346460 Free PMC article. - Islet-Resident Dendritic Cells and Macrophages in Type 1 Diabetes: In Search of Bigfoot's Print.
Zirpel H, Roep BO. Zirpel H, et al. Front Endocrinol (Lausanne). 2021 Apr 12;12:666795. doi: 10.3389/fendo.2021.666795. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33912139 Free PMC article. Review. - Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?
Funda DP, Palová-Jelínková L, Goliáš J, Kroulíková Z, Fajstová A, Hudcovic T, Špíšek R. Funda DP, et al. Front Immunol. 2019 May 14;10:967. doi: 10.3389/fimmu.2019.00967. eCollection 2019. Front Immunol. 2019. PMID: 31139178 Free PMC article. Review. - Tolerising cellular therapies: what is their promise for autoimmune disease?
Mosanya CH, Isaacs JD. Mosanya CH, et al. Ann Rheum Dis. 2019 Mar;78(3):297-310. doi: 10.1136/annrheumdis-2018-214024. Epub 2018 Nov 2. Ann Rheum Dis. 2019. PMID: 30389690 Free PMC article. Review. - Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice.
Lo J, Xia CQ, Peng R, Clare-Salzler MJ. Lo J, et al. J Immunol Res. 2018 Feb 14;2018:5463879. doi: 10.1155/2018/5463879. eCollection 2018. J Immunol Res. 2018. PMID: 29651443 Free PMC article.
References
- Diabetologia. 1991 Jan;34(1):2-5 - PubMed
- J Exp Med. 1992 Jan 1;175(1):131-8 - PubMed
- Diabetes. 1990 May;39(5):583-9 - PubMed
- Proc Natl Acad Sci U S A. 1985 Jul;82(13):4495-7 - PubMed
- Cell Immunol. 1985 Sep;94(2):435-9 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical